Sinecod (citrate butamirate) syrup 1.5 mg/ml. 100 ml. vial

Sinecod (citrate butamirate) syrup 1.5 mg/ml. 100 ml. vial

$21.00

Manufacturer: Italy

Symptomatic treatment of cough (including dry) of various origins.

Categories: , ,

Description

Sinecod (citrate butamirate) syrup 1.5 mg/ml. 100 ml. vial

Composition

active ingredient: butamirate citrate;

1 ml of syrup contains 1.5 mg of butamirate citrate;

excipients: sorbitol solution 70% (E 420), glycerin, sodium saccharin, benzoic acid (E 210), vanillin, ethanol 96%, sodium hydroxide 30%, purified water.

Dosage form

Syrup.

Basic physical and chemical properties: a clear solution from colorless to brownish-yellowish.

Pharmacological group

Means used for coughs and colds. Cough suppressants.
Code ATX R05D B13.

Pharmacological properties

Non-opiate antitussive agent with central action. However, the exact mechanism of action remains unknown.

The active ingredient of Sinekod is butamirate citrate, which depresses cough and differs in structure and pharmacological action from opium alkaloids. It is believed that this substance acts on the central nervous system. Butamirate citrate causes a non-specific anticholinergic and bronchospasmolytic effect, which improves respiratory function. Synekod does not entail addiction or dependence.

Butamirate citrate has a wide therapeutic range, so Sinekod is well tolerated at therapeutic doses and is well suited as a cough suppressant in children.

Indications

Sinecod syrup is used in the treatment of a non-productive, wasting cough. It is prescribed for the treatment of dry, debilitating cough with whooping cough, cough of smokers and dry cough that occurs with infectious and inflammatory lesions of the respiratory system.
Such use of Sinecod syrup is advisable for suppressing the cough reflex during diagnostic studies (for example, bronchoscopy) and surgical treatment of the respiratory system.

Contraindications

Sinekod is not used for hypersensitivity to butamirate citrate, pulmonary hemorrhage, the first trimester of pregnancy and lactation.
Sinecode in syrup is not used in the treatment of children under three years of age, and in drops – under 2 months.
The drug is used with caution in the therapy of women in the II and III trimesters of pregnancy, as well as in patients who have a history of drug or alcohol dependence, liver disease, epilepsy and brain damage, since the drug contains ethyl alcohol.

Application during pregnancy and lactation

Due to the fact that no studies have been conducted on the effect of Sinekod on fetal development, its use in the therapy of the first trimester of pregnancy is impossible. The use of Sinekod in the II and III trimesters is possible only with a careful balance of benefits and harms from its use.
The appointment of Sinekod during lactation is possible only after refusal to breastfeed, since it is not known whether butamirate citrate is able or not to penetrate into breast milk and what effect it can have on the development of the newborn.

Method of administration and dosage

When using Sinecod syrup, children from 3 to 6 years old use the drug in 5 ml, from 6 to 12 years – 10 ml, from 12 years old and older – 15 ml three times a day, adults and children over 15 years old – 15 ml from 3 to 4 times a day. For the most accurate dosage of syrup, a measuring cap should be used.

Overdose

When taking Sinekod in high doses, it is possible to develop nausea, vomiting, diarrhea, severe drowsiness, dizziness, lowering blood pressure and loss of consciousness.
In case of an overdose, gastric lavage is carried out, an abundant drink and activated carbon are provided. Also, the patient was shown the appointment of osmotic laxatives and symptomatic treatment.

Side effects

When taking Sinekod, some patients develop fatigue, headaches, dyspeptic disorders, sleep disorders and allergic reactions.

Related products